Jenburkt Pharmaceuticals has informed that the trading window for all the trades in the equity shares of the Company by any of the designated persons and insiders of the Company, including their immediate relative(s), shall remain closed from 1st April, 2022 till 48 hours after the price sensitive information viz. audited financial results, pertaining to the quarter and financial year ended on 31st March, 2022 are disseminated or made public. The Company shall intimate the exchange separately about the schedule of Board Meeting for considering the said unaudited financial results, in due course.
The above information is a part of company’s filings submitted to BSE.